New AI Cancer Vaccine? Not so FAST!

Wow, there was quite an announcement today stating that soon, through a simple blood test, we can use artificial intelligence (AI) to diagnose cancer and develop a unique, specific vaccine within 48 hours. This is a big claim; one may even say it is propaganda hype. But wait, this grand announcement was given to us by a respected, experienced Oncologist, right? Well…no.

Larry Ellison is a businessman and entrepreneur who co-founded software company Oracle Corporation, which is now co-invested in funding the infrastructure behind the AI technology along with OpenAI, SoftBank and others planning to cash in on sick Americans. The business of medicine could not have been made more blatantly evident with today’ announcement.

The money that continues to pour into these vile funnels of false healthcare is staggering. Last week, the Biden administration awarded Moderna $590 million to fund its work on mRNA vaccines for bird flu and other influenza strains with “pandemic potential,” the U.S. Department of Health and Human Services reported. Now, Trump cheered his political support for a $500 billion private-sector project called Stargate. “It is deeply concerning, though not entirely surprising, that the incoming Trump administration is continuing to pursue massive funding for mRNA technology, including speculative cancer therapies,” author and natural health expert Sayer Ji stated.

“That is not a vaccine,” Children’s Health Defense CEO Mary Holland said, commenting on the concept of a new mRNA “vaccine” for cancer. “That’s a gene therapy. What we’ve seen from the COVID mRNA shots is that they’ve been disastrous for the immune system.” We certainly can’t argue with that comment if we open our eyes to the data.

Why would this therapy be patented as a “vaccine”? Immunotherapy, chemotherapy, and radiation therapy, the current three staples in the oncologist’s pocket are classified honestly and misuse of such as well as dangers and side-effects have been deeply studied and the makers are NOT immune to law suits. However, classifying a therapy as a vaccine carries exclusive protection under current law against improperly studied ill-effects.

While I am on the side of innovation and forward-thinking, it seems that is more about money and less about healthcare. Would I run out and pay $500,000 per dose of Larry’s gene therapy? Probably not. I share a few thoughts in this video:

Screen Shot 2025 01 22 at 10.38.21 PM